Literature DB >> 29364437

Prepubertal and postpubertal vitiligo: a multivariate comparative study in 375 patients.

Huma Khurrum1, Khalid M AlGhamdi2.   

Abstract

BACKGROUND: The onset of vitiligo during childhood is common. Limited data exist that compare the clinical associations of prepubertal and postpubertal vitiligo in Arabs.
OBJECTIVE: To compare the clinical profile of pre and postpubertal onset vitiligo.
METHODS: A cross-sectional observational study was conducted. The Vitiligo European Task Force questionnaire was completed for each patient.
RESULTS: A total of 375 patients were included; 199 had postpubertal vitiligo (>12 years), and 176 had prepubertal onset vitiligo (<12years). There were more females in the prepubertal group (49%) than in the postpubertal group (29%), p-value <0.001. The prepubertal group has had more involvement than the postpubertal group (45% vs 30%, p=0.004). Only 8 cases of segmental vitiligo were observed; five were observed in the prepubertal group of patients. Female gender (OR=2.3; 95% CI:1.5, 3.5), presence of halo nevus (OR=2.2; 95% CI:1.1, 4.4) and face involvement (OR=1.9; 95% CI:1.2, 2.9) were positively associated with prepubertal vitiligo. Stress, as an onset factor, was positively associated (OR=0.51; 95% CI:0.3, 0.8) with postpubertal onset vitiligo. STUDY LIMITATIONS: A possible selection bias toward more severe vitiligo cases can be a limitation, because the study was conducted in a clinic specialized in vitiligo. Moreover, a likelihood of false recall bias cannot be excluded.
CONCLUSIONS: Our data present clinical evidence that vitiligo behaves mostly the same way in the prepubertal group as in the postpubertal group. However, female over-representation, more face involvement and more halo nevi were observed in prepubertal vitiligo, while stress was more prevalent as an aggravating factor in postpubertal vitiligo patients.

Entities:  

Mesh:

Year:  2017        PMID: 29364437      PMCID: PMC5786395          DOI: 10.1590/abd1806-4841.20176154

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


INTRODUCTION

Vitiligo is mainly an acquired depigmentary disorder affecting around 1% of the world's population.[1-3] In 25% of the cases, it begins prior to 14 years of age.[4] The mean age of onset varied from 4 to 8 years among different studies. The mean age of onset in Caucasians is 24 years.[5-7] Vitiligo can occur in infants as young as 3 months old. Congenital vitiligo has been described previously.[8] Prepubertal vitiligo may differ from postpubertal vitiligo. To date, few reports have addressed differences between true paediatric vitiligo/prepubertal onset vitiligo (before the age of 12) and later-onset vitiligo (after the age of 12, postpubertal onset vitiligo).[3,9,10] There is an inadequate number of studies comparing various associated clinical factors with both prepubertal and postpubertal vitiligo forms. The present study shows the results of a cross-sectional observational study, after having received ethical clearance from the institutional board review of King Khalid University hospital, aimed at identifying factors associated with prepubertal and postpubertal onset vitiligo using univariate and multivariate logistic regression analyses.

METHODS

This research conducted an observational cross-sectional study in the dermatology clinic at King Khalid University Hospital between January 1, 2008, and July 1, 2012. Ethics committee approval was obtained from the university's review board. All patients with vitiligo, defined as an acquired progressive depigmentation according to the Vitiligo European Task Force (VETF) definition, were enrolled in this study.[11] The VETF questionnaires were completed by each vitiligo patient attending the clinic on his/her first visit.[12] The VETF form provided a wide range of demographic and clinical information, including sex, age, age at onset of vitiligo, phototype, site of involvement and distribution patterns, Koebner phenomenon (KP, defined in the VETF grid as depigmentation on scars), presence of halo nevi, family history of vitiligo, personal and/or family history of chronic autoimmune/autoinflammatory diseases (thyroid disease, atopy, rheumatoid arthritis, psoriasis, type 1 diabetes mellitus, alopecia areata or inflammatory bowel disease), family history of premature greying of hair (more than 50% of white hair before the age of 40), emotional stress at onset and response to treatment, if any.

Statistical analysis

Patient characteristics were summarized as counts and percentages, and were compared between prepubertal onset (≤ 12 years) and postpubertal onset vitiligo (> 12 years) using a chi-squared test. Logistic regression analysis was used to study the effect of risk factors on the age at onset of prepubertal vitiligo, and odds ratios with 95% confidence intervals were computed. The analyses were performed without adjustments for each of the potential risk factors and were further adjusted by entering clinically important covariates in the adjusted multivariable model. All p-values were considered to be statistically significant at the 5% level. Hosmer and Lemeshow goodness-of-fit was used to test the adequacy of the logistic regression model. Statistical analyses were performed using STATA statistical software version 13 (StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP).

RESULTS

Demographic and clinical characteristics of patients

A total of 375 patients were included, of which 176 (male 90, female 86) were in the prepubertal group, and 199 (male 140, female 59) were in the postpubertal vitiligo onset group (Table 1). More males were observed in the postpubertal group (70.4% vs. 51%), while females were observed more in the prepubertal group than in the postpubertal group (49% vs. 29.6%), p value < 0.001. Disease durations of ≤ 3 years were 37.2% and 39.4% in the prepubertal and postpubertal groups, respectively. Emotional stress as an aggravating factor was observed more in the postpubertal group (24.1%) when compared to the prepubertal group (9.7%). The presence of one or more halo nevi was observed more often (13.1%) in the prepubertal group when compared to the postpubertal group (6.5%). With regards to the previous episode of spontaneous regimentation, there was a significant difference of 9.7% and 19.6%, respectively, in the prepubertal and postpubertal groups. The prepubertal vitiligo group is associated with a family history of premature greying of hairs (p= 0.05).
Table 1

Description of patient characteristics according to the age of vitiligo onset (≤ 12 years vs > 12 years) (n=375)

Demographic and clinical dataPrepubertal onset of vitiligoPostpubertal onset of vitiligop
(≤ 12 years), n=176(>12 years) n=199
n%n%
Gender (n=369)    <0.001
Male90 51.1140 70.4 
Female86 48.959 29.6 
Duration of disease (n=370)    0.67
≤ 3y64 37.278 39.4 
> 3y108 62.8120 60.6 
Koebner phenomenon (n=371)    0.56
Yes47 26.958 29.6 
No128 73.1138 70.4 
Emotional stress as onset factor (n=375)    0.001
Triggering31 17.636 18.1 
Aggravating factor17 9.748 24.1 
Has no relation128 72.7115 57.8 
Presence of halo nevus (n=375)    0.03
None153 86.9186 93.5 
One or more23 13.113 6.5 
Previous episode of repigmentation (n=375)    0.02
None73 41.578 39.2 
Spontaneous179.739 19.6 
Following Rx84 47.782 41.2 
After sun exposure2 1.10 0 
Type of vitiligo (n=370)    0.332
Focal35 20.253 26.9 
Segmental5 2.83 1.5 
Acrofacial37 21.434 17.3 
Generalised vitiligo73 42.277 39.1 
Mucosal1 0.55 2.5 
Mixed22 12.725 12.7 
Description of patient characteristics according to the age of vitiligo onset (≤ 12 years vs > 12 years) (n=375) No significant difference was observed between a family history of vitiligo or autoimmune disease with respect to the vitiligo onset in either group. The personal history of autoimmune disease was similar in both groups (Table 2). Generalised vitiligo was the predominant type of disease observed during consultation for both groups. Facial involvement was identified more often in the prepubertal group (44.9%) when compared to the postpubertal group (30.2%).
Table 2

Description of other patient characteristics according to the age of vitiligo onset (≤ 12 years versus > 12 years ) (n=375)

 Prepubertal onset of vitiligoPostpubertal onset of vitiligop
(≤ 12 years) n=176(≤ 12 years) n=199
n%n%
Personal history of autoimmune disease (n=375)    0.44
Yes169.12311.6 
No16090.917688.4 
Family history of premature greying of hair (n=375)    0.05
Yes2815.9199.6 
No14884.118090.4 
Family history of vitiligo (n=371)    0.47
Yes8649.18945.4 
No8950.910754.6 
Family history of autoimmune disease (n=375)    0.47
Yes5128.95125.6 
No12571.014874.4 
Description of other patient characteristics according to the age of vitiligo onset (≤ 12 years versus > 12 years ) (n=375)

Logistic Regression Analysis

Results of univariate logistic regression of very early onset for clinically important patient characteristics are presented in table 3. Female gender (OR=2.3; 95% CI:1.5, 3.5), presence of halo nevus (OR=2.2; 95% CI:1.1, 4.4) and face involvement (OR=1.9; 95% CI:1.2, 2.9) were positively associated with early-onset vitiligo. Stress as an onset factor was positively associated (OR=0.51; 95% CI:0.3, 0.8) with postpubertal onset vitiligo. No significant difference was observed in the distribution of previous episodes of spontaneous repigmentation, disease duration, Koebner's phenomenon, personal and family history of premature greying of hair, and family history of vitiligo and/or autoimmune disease.
Table 3

Univariate logistic regression for prepubertal (≤ 12) vs postpubertal onset of vitiligo (> 12) (n=357)

Gender (female)OR95% CINP
2.261.5-3.5375<0.001
Previous episode of spontaneous repigmentation (yes/no)0.9090.6 - 1.43750.65
Presence of Koebner phenomenon (yes/ no)0.8730.6 - 1.43710.56
Stress as an aggravating factor (yes/ no)0.5130.3- 0.83750.003
Disease duration (> 3 years/ ≤ 3 years)1.0960.7 - 1.73700.67
Halo nevus (yes/ no)2.1501.1 - 4.43750.035
Family history of premature greying of hair (yes/ no)1.7920.9 - 3.33750.06
Family history of vitiligo (yes/ no)1.1620.8 - 1.73710.47
Personal history of autoimmune disease (yes/ no)0.7650.4 - 1.53750.44
Family history of autoimmune disease (yes/ no)1.1840.7 - 1.93750.47
Face involvement (yes/no)1.8871.2-2.93750.003

OR- unadjusted odds ratio; CI- Confidence interval

Univariate logistic regression for prepubertal (≤ 12) vs postpubertal onset of vitiligo (> 12) (n=357) OR- unadjusted odds ratio; CI- Confidence interval When all of the patient characteristics were included simultaneously in the logistic regression analysis, female gender (OR=2.4; 95% CI:1.6, 3.9, P<0.001), stress as an aggravating factor (OR=0.45; 95% CI:0.3,0.7, P=0.001), halo nevus (OR=2.4; 95% CI:1.1, 5.4, P=0.03) and face involvement (OR=1.8; 95% CI:1.1, 2.8, P=0.01) remained statistically significant (Table 4). The logistic regression model results using Hosmer-Lemeshow goodness-of fit were good (p=0.77).
Table 4

Multivariable logistic regression for prepubertal (≤ 12 years) vs postpubertal onset of vitiligo (> 12 years) (n=357)

 AOR95% CIP
Gender (female)2.471.6-3.9<0.001
Previous episode of spontaneous repigmentation (yes/no)0.780.5 - 1.30.31
Presence of Koebner phenomenon (yes/ no)0.990.6 - 1.70.98
Stress as an aggravating factor (yes/ no)0.450.3- 0.70.001
Disease duration (> 3 years/ ≤ 3 years)1.280.8 - 2.10.30
Halo nevus (yes/ no)2.411.1 - 5.40.03
Family history of premature greying of hair (yes/ no)1.370.7 - 2.60.35
Family history of vitiligo (yes/ no)1.180.8 - 1.90.46
Personal history of autoimmune disease (yes/ no)0.590.3 - 1.30.18
Family history of autoimmune disease (yes/ no)1.190.7 - 1.90.48
Face involvement (yes/no)1.791.1-2.80.01

AOR- Adjusted Odds ratio; CI= Confidence interval

Multivariable logistic regression for prepubertal (≤ 12 years) vs postpubertal onset of vitiligo (> 12 years) (n=357) AOR- Adjusted Odds ratio; CI= Confidence interval

DISCUSSION

The purpose of this study was to compare prepubertal and postpubertal vitiligo in clinical and epidemiologic settings. In our study, a female gender preference was noted for prepubertal vitiligo. Other studies also report a female preponderance of 57%[5-7] to 63%,[3] and in our study, this percentage was even higher (66%). Other studies express equal numbers of patients for both genders.[3,5] Whether girls are overrepresented in childhood, compared with late-onset vitiligo, is also ambiguous. We found a significant difference in the female:male ratio between prepubertal and postpubertal vitiligo. Childhood vitiligo was reported to vary from adults by AOR-Adjusted Odds ratio; CI= Confidence interval showing a higher incidence in females; segmental vitiligo was more common and was less frequently linked to other systemic autoimmune and endocrine disorders.[12] The present study also found more segmental cases in the prepubertal group. Regarding the preliminary presentation site of prepubertal vitiligo, our results are in agreement with previous studies that reported the head and neck area as the most common site and the upper extremities as the least common site.[13] Psychological stress has been associated with vitiligo onset and progression. In one study, 44% of the patients with vitiligo referred to stress as the cause of their disease.[14] A significant difference in the mean number of stressful events between patients with vitiligo and control subjects has also been reported.[15] In a paediatric vitiligo population, disease onset has been connected to psychological aspects in 57% of the patients.[16] Patients with postpubertal vitiligo associated stress with a statistically significant higher frequency (p=0.003). Nevertheless, we cannot eliminate a recall bias in this difference, because patients with childhood vitiligo might be unable to recall stress events. Vitiligo may be associated with other autoimmune disorders, such as alopecia areata, diabetes mellitus, pernicious anaemia, Addison's disease and thyroid disorder. One Indian study associated autoimmune disorders in 1.3% of the children with vitiligo.[7] Numerous authors have reported vitiligo-associated autoimmune disorders occurring solely in children suffering from NSV.[17] In the study by Hann et al.[13], associated autoimmune disorders were found in 3.4% of children with SV. In our study, the prevalence of thyroid diseases was not significantly dissimilar in patients with prepubertal vitiligo when compared to patients with postpubertal disease. An interesting finding that, to the best of our knowledge, has not been reported before is that the prepubertal vitiligo group is associated with a family history of the premature greying of hair (p= 0.05). Compared to the general population, patients with vitiligo have higher rates of a positive family history of the disease.[12,18] In our study, 49.1% of the patients with childhood-onset vitiligo and 45.1% of the patients with later onset vitiligo had a positive family history of the disease. No discrimination was found between the two groups, as has also been reported elsewhere.[3,9] This study found no disparity in the positive family history rate between patients with early versus late disease onset. A positive family history of thyroid disease has been described in 32% to 43% of children with vitiligo, but in our study, no significant difference was observed in the family history of vitiligo in either group.[12,19] A positive family history for the premature greying of hairs is more common in the prepubertal vitiligo group. In an earlier study, a strong connection was found between halo nevi associated-non-segmental vitiligo and the premature greying of hair, suggesting that the latter may involve an autoimmune process.[20] This hypothesis may be reinforced by the fact that in our population of vitiligo with prepubertal onset, halo nevus was observed more often (p=0.03). Our study found that patients with a prepubertal onset of vitiligo had a lesser chance of spontaneous repigmentation (p=0.02). This may possibly support the early treatment of children with vitiligo, in which it is well-known that in vitiligo, treatment is more effective in fresh lesions as compared to older lesions.[20] The limitations of this study include a possible selection bias toward more severe vitiligo cases, given that the study was conducted in a clinic specialized in vitiligo. Additionally, a possibility of false recall bias cannot be excluded, as patients with childhood vitiligo might be incapable of accurately remembering the period of disease onset. The strong points of this study consist of a large sample size, the first of its kind in the Middle East, and the advanced statistical methods used in the analysis.

CONCLUSION

Prepubertal onset vitiligo, when compared to postpubertal vitiligo, has distinct clinical features. No associations of thyroid abnormalities or atopic dermatitis were found with prepubertal or postpubertal vitiligo. Stress as an aggravating factor was observed more often in the postpubertal group, while prepubertal vitiligo patients had more face involvement. Further epidemiological studies are needed to establish the relationships of different factors; in particular, genetic studies should be taken into account for both prepubertal and postpubertal vitiligo. Future analysis of various factors are needed in order to establish the cause of vitiligo and to guide professionals toward a proper target therapy.
  19 in total

1.  Recent onset vitiligo on acral areas treated with phototherapy: need of early treatment.

Authors:  Dong-Youn Lee; Cho-Rok Kim; Joo-Heung Lee
Journal:  Photodermatol Photoimmunol Photomed       Date:  2010-10       Impact factor: 3.135

2.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force.

Authors:  Alain Taïeb; Mauro Picardo
Journal:  Pigment Cell Res       Date:  2007-02

3.  Segmental vitiligo: clinical findings in 208 patients.

Authors:  S K Hann; H J Lee
Journal:  J Am Acad Dermatol       Date:  1996-11       Impact factor: 11.527

4.  Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients.

Authors:  K Ezzedine; A Diallo; C Léauté-Labrèze; D Mossalayi; Y Gauthier; S Bouchtnei; M Cario-André; J Seneschal; F Boralevi; T Jouary; A Taieb
Journal:  Br J Dermatol       Date:  2011-06-02       Impact factor: 9.302

5.  Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study.

Authors:  Juliette Mazereeuw-Hautier; Sophie Bezio; Emmanuel Mahe; Christine Bodemer; Catherine Eschard; Valérie Viseux; Christine Labreze; Patrice Plantin; Sebastien Barbarot; Pierre Vabres; Ludovic Martin; Carle Paul; Jean-Philippe Lacour
Journal:  J Am Acad Dermatol       Date:  2010-06       Impact factor: 11.527

6.  The relationship between family medical history and childhood vitiligo.

Authors:  Urvi Pajvani; Naurin Ahmad; Andrew Wiley; Ross M Levy; Roopal Kundu; Anthony J Mancini; Sarah Chamlin; Annette Wagner; Amy S Paller
Journal:  J Am Acad Dermatol       Date:  2006-05-18       Impact factor: 11.527

7.  Profile of childhood vitiligo in China: an analysis of 541 patients.

Authors:  Zhi Hu; Jiang-Bo Liu; Sui-Sui Ma; Sen Yang; Xue-Jun Zhang
Journal:  Pediatr Dermatol       Date:  2006 Mar-Apr       Impact factor: 1.588

8.  Epidemiology of childhood vitiligo: a study of 625 patients from north India.

Authors:  Sanjeev Handa; Sunil Dogra
Journal:  Pediatr Dermatol       Date:  2003 May-Jun       Impact factor: 1.588

9.  Congenital stable symmetrical type vitiligo in a patient whose mother developed vitiligo during pregnancy.

Authors:  Andrea L Kedward; David J Gawkrodger
Journal:  Eur J Dermatol       Date:  2008 May-Jun       Impact factor: 3.328

Review 10.  Vitiligo in children.

Authors:  Talia Kakourou
Journal:  World J Pediatr       Date:  2009-11-13       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.